The translocation of IRF3 and NF‐κB to the cell nucleus drives the expression of interferons (IFNs) and cytokines, ultimately inhibiting tumor initiation and development (Bose 2017; Gan et al. 2021). This evidence concerns the gene NFKB1 and neoplasm.